![](/images/graphics-bg.png)
Ovatodiolide Targets β-Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma
المؤلفون المشاركون
Hsu, Ren-Jun
Wu, Chieh-Lin
Chang, Wen-Liang
Ho, Jar-Yi
Yu, Cheng-Ping
Yu, Dah-Shyong
Cha, Tai-Lung
المصدر
Evidence-Based Complementary and Alternative Medicine
العدد
المجلد 2013، العدد 2013 (31 ديسمبر/كانون الأول 2013)، ص ص. 1-16، 16ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2013-05-26
دولة النشر
مصر
عدد الصفحات
16
التخصصات الرئيسية
الملخص EN
Dysregulated β-catenin signaling is intricately involved in renal cell carcinoma (RCC) carcinogenesis and progression.
Determining potential β-catenin signaling inhibitors would be helpful in ameliorating drug resistance in advanced or metastatic RCC.
Screening for β-catenin signaling inhibitors involved in silico inquiry of the PubChem Bioactivity database followed by TCF/LEF reporter assay.
The biological effects of ovatodiolide were evaluated in 4 RCC cell lines in vitro and 2 RCC cell lines in a mouse xenograft model.
The synergistic effects of ovatodiolide and sorafenib or sunitinib were examined in 2 TKI-resistant RCC cell lines.
Ovatodiolide, a pure compound of Anisomeles indica, inhibited β-catenin signaling and reduced RCC cell viability, survival, migration/invasion, and in vitro cell or in vivo mouse tumorigenicity.
Cytotoxicity was significantly reduced in a normal kidney epithelial cell line with the treatment.
Ovatodiolide reduced phosphorylated β-catenin (S552) that inhibited β-catenin nuclear translocation.
Moreover, ovatodiolide decreased β-catenin stability and impaired the association of β-catenin and transcription factor 4.
Ovatodiolide combined with sorafenib or sunitinib overcame drug resistance in TKI-resistant RCC cells.
Ovatodiolide may be a potent β-catenin signaling inhibitor, with synergistic effects with sorafenib or sunitinib, and therefore, a useful candidate for improving RCC therapy.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Ho, Jar-Yi& Hsu, Ren-Jun& Wu, Chieh-Lin& Chang, Wen-Liang& Cha, Tai-Lung& Yu, Dah-Shyong…[et al.]. 2013. Ovatodiolide Targets β-Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma. Evidence-Based Complementary and Alternative Medicine،Vol. 2013, no. 2013, pp.1-16.
https://search.emarefa.net/detail/BIM-450756
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Ho, Jar-Yi…[et al.]. Ovatodiolide Targets β-Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma. Evidence-Based Complementary and Alternative Medicine No. 2013 (2013), pp.1-16.
https://search.emarefa.net/detail/BIM-450756
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Ho, Jar-Yi& Hsu, Ren-Jun& Wu, Chieh-Lin& Chang, Wen-Liang& Cha, Tai-Lung& Yu, Dah-Shyong…[et al.]. Ovatodiolide Targets β-Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma. Evidence-Based Complementary and Alternative Medicine. 2013. Vol. 2013, no. 2013, pp.1-16.
https://search.emarefa.net/detail/BIM-450756
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-450756
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)